Aller au contenu principal
Profil bibliographique

Rebecca Lu

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

19Publications signalées
261Citations signalées
0Affiliations récentes

Les domaines associés

Multiple Myeloma Research and TreatmentsAmyloidosis: Diagnosis, Treatment, OutcomesCutaneous lymphoproliferative disorders researchProtein Degradation and InhibitorsMultiple Sclerosis Research Studies

Les publications récentes

Accès ouvert 2024 article OpenAlex

Diversity, Equity, and Inclusion in Multiple Myeloma: A Call to Action

Rebecca Lu, Joseph D Tariman, Donna Catamero, Michaela Hillengaß et autres

Background: Although advancements in multiple myeloma therapy have rapidly evolved, pervasive racial and social inequities prevent uniform benefit across diverse patient populations. This affects access to US Food and Drug Administration-approved treatments and to clinical studies. The impact of health-care inequities is …

us (code pays fourni par la source)

1 citation Journal of the Advanced Practitioner in Oncology
Accès ouvert 2023 article OpenAlex

Management of Ocular Toxicity in Patients Receiving Belantamab Mafodotin

Rebecca Lu, Ashley N. Morphey, Felicia Diaz, Jessica Chen et autres

While significant strides have been made in the treatment of multiple myeloma, treatment options remain limited and definite, and most patients ultimately succumb to their disease. The urgency for more treatment modalities remains, as patients who are refractory to proteasome inhibitors, immunomodulatory …

us (code pays fourni par la source)

11 citations Journal of the Advanced Practitioner in Oncology
Accès ouvert 2022 article OpenAlex

A Focus on Waldenström Macroglobulinemia and AL Amyloidosis

Rebecca Lu, Tiffany Ann Richards

Waldenström macroglobulinemia (WM) is a lymphoplasmacytic lymphoma that is characterized by the overproduction of an IgM monoclonal protein. It may cause adenopathy, hepatomegaly, splenomegaly, as well as other disease-related complications such as cold agglutinin anemia, cryoglobulinemia, hyperviscosity, and neuropathy. While light chain …

us (code pays fourni par la source)

6 citations Journal of the Advanced Practitioner in Oncology
Accès ouvert 2021 article OpenAlex

A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma

Hans C. Lee, Lei Feng, Onyeka Oriabure, Vivian Graham et autres

To the Editor: The incorporation of novel agents including immunomodulatory drugs (IMiDs), proteasome inhibitors (PIs), and monoclonal antibodies (mAbs) to myeloma treatment regimens have led to substantial gains in overall survival in patients with multiple myeloma over the last 10–15 years. However, …

us (code pays fourni par la source)

4 citations American Journal of Hematology
Accès ouvert 2019 article OpenAlex

AL Amyloidosis: Unfolding a Complex Disease

Rebecca Lu

Light chain (AL) amyloidosis is a rare plasma cell dyscrasia. An estimated 12,000 people live with the disease in the United States. AL amyloidosis occurs from the misfolding of proteins that deposit in organs (heart, kidneys, digestive tract, tongue, lungs, and nervous …

us (code pays fourni par la source)

15 citations Journal of the Advanced Practitioner in Oncology
Accès ouvert 2019 article OpenAlex

A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

Hans C. Lee, Jatin J. Shah, Lei Feng, Elisabet Esteve Manasanch et autres

The use of novel agents including immunodulatory drugs (IMiDs), proteasome inhibitors (PIs), and more recently anti-CD38 monoclonal antibodies has produced a substantial improvement in response rates and response durability in multiple myeloma patients. However, myeloma remains largely incurable, and the majority of …

us (code pays fourni par la source)

27 citations Blood Cancer Journal
Accès ouvert 2017 article OpenAlex

Efficacy and Safety of a Bovine-Associated Staphylococcus aureus Phage Cocktail in a Murine Model of Mastitis

Koen Breyne, Ryan William Honaker, Zachary Hobbs, Manuela Friederike Richter et autres

Overuse of antibiotics is a major problem in the treatment of bovine mastitis, and antibiotic treatment is frequently non-curative, thus alternative treatments are necessary. The primary aim of this study was to evaluate the efficacy of a purified phage cocktail for treatment …

be, us (code pays fourni par la source)

95 citations Frontiers in Microbiology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.